These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 12946588)

  • 1. No association between micrometer-sized particles in human cerebrospinal fluid and schizophrenia.
    Ekelund J; Wahlbeck K; Bäck N
    Neurosci Lett; 2003 Sep; 349(1):68-70. PubMed ID: 12946588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micrometer-sized particles in cerebrospinal fluid (CSF) in patients with schizophrenia.
    Wetterberg L; Nybom R; Bratlid T; Fladby T; Olsson B; Wigzell H
    Neurosci Lett; 2002 Aug; 329(1):91-5. PubMed ID: 12161270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micrometer-sized thread-like and/or spherical particles in the first fraction of cerebrospinal fluid in patients with bipolar disorder.
    Båve U; Nybom R; Landén M; Wetterberg L
    Bipolar Disord; 2010 May; 12(3):298-305. PubMed ID: 20565436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-cerebrospinal fluid barrier impairment as indicator for an immune process in schizophrenia.
    Schwarz MJ; Ackenheil M; Riedel M; Müller N
    Neurosci Lett; 1998 Sep; 253(3):201-3. PubMed ID: 9792246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis.
    Orlovska-Waast S; Köhler-Forsberg O; Brix SW; Nordentoft M; Kondziella D; Krogh J; Benros ME
    Mol Psychiatry; 2019 Jun; 24(6):869-887. PubMed ID: 30116031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of macrophages in the CSF of schizophrenic patients during acute psychotic episodes.
    Nikkilä HV; Müller K; Ahokas A; Miettinen K; Rimón R; Andersson LC
    Am J Psychiatry; 1999 Nov; 156(11):1725-9. PubMed ID: 10553735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid D-serine and glycine concentrations are unaltered and unaffected by olanzapine therapy in male schizophrenic patients.
    Fuchs SA; De Barse MM; Scheepers FE; Cahn W; Dorland L; de Sain-van der Velden MG; Klomp LW; Berger R; Kahn RS; de Koning TJ
    Eur Neuropsychopharmacol; 2008 May; 18(5):333-8. PubMed ID: 18261886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical subtypes of schizophrenia: differences in brain and CSF volume.
    Gur RE; Mozley PD; Shtasel DL; Cannon TD; Gallacher F; Turetsky B; Grossman R; Gur RC
    Am J Psychiatry; 1994 Mar; 151(3):343-50. PubMed ID: 8109642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative correlation between cerebrospinal fluid oxytocin levels and negative symptoms of male patients with schizophrenia.
    Sasayama D; Hattori K; Teraishi T; Hori H; Ota M; Yoshida S; Arima K; Higuchi T; Amano N; Kunugi H
    Schizophr Res; 2012 Aug; 139(1-3):201-6. PubMed ID: 22742979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An investigation of the effects of intracerebral injection in the marmoset of cytopathic cerebrospinal fluid from patients with schizophrenia or neurological disease.
    Baker HF; Ridley RM; Crow TJ; Bloxham CA; Parry RP; Tyrrell DA
    Psychol Med; 1983 Aug; 13(3):499-511. PubMed ID: 6226054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher cerebrospinal fluid angiotensin-converting enzyme levels in neuroleptic-treated than in drug-free patients with schizophrenia.
    Wahlbeck K; Ahokas A; Miettinen K; Nikkilä H; Rimón R
    Schizophr Bull; 1998; 24(3):391-7. PubMed ID: 9718631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between cerebrospinal fluid, gray matter and white matter changes in families with schizophrenia.
    Schneider-Axmann T; Kamer T; Moroni M; Maric N; Tepest R; Dani I; Honer WG; Scherk H; Rietschel M; Schulze TG; Müller DJ; Cordes J; Schönell H; Steinmetz H; Gaebel W; Vogeley K; Kühn KU; Wagner M; Maier W; Träber F; Block W; Schild HH; Falkai P
    J Psychiatr Res; 2006 Oct; 40(7):646-55. PubMed ID: 16019030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia.
    Holmes E; Tsang TM; Huang JT; Leweke FM; Koethe D; Gerth CW; Nolden BM; Gross S; Schreiber D; Nicholson JK; Bahn S
    PLoS Med; 2006 Aug; 3(8):e327. PubMed ID: 16933966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased frequency of activated lymphocytes in the cerebrospinal fluid of patients with acute schizophrenia.
    Nikkilä HV; Müller K; Ahokas A; Rimón R; Andersson LC
    Schizophr Res; 2001 Apr; 49(1-2):99-105. PubMed ID: 11343869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotensin-like immunoreactivity in cerebrospinal fluid of patients with schizophrenia, depression, anorexia nervosa-bulimia, and premenstrual syndrome.
    Nemeroff CB; Bissette G; Widerlov E; Beckmann H; Gerner R; Manberg PJ; Lindstrom L; Prange AJ; Gattaz WF
    J Neuropsychiatry Clin Neurosci; 1989; 1(1):16-20. PubMed ID: 2577718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between dopamine D2 receptor occupancy, clinical response, and drug and monoamine metabolites levels in plasma and cerebrospinal fluid. A pilot study in patients suffering from first-episode schizophrenia treated with quetiapine.
    Nikisch G; Baumann P; Kiessling B; Reinert M; Wiedemann G; Kehr J; Mathé AA; Piel M; Roesch F; Weisser H; Schneider P; Hertel A
    J Psychiatr Res; 2010 Sep; 44(12):754-9. PubMed ID: 20176367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder.
    Sasayama D; Hattori K; Wakabayashi C; Teraishi T; Hori H; Ota M; Yoshida S; Arima K; Higuchi T; Amano N; Kunugi H
    J Psychiatr Res; 2013 Mar; 47(3):401-6. PubMed ID: 23290488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF-studies in neuropsychiatric disorders.
    Raedler TJ; Wiedemann K
    Neuro Endocrinol Lett; 2006 Jun; 27(3):297-305. PubMed ID: 16807525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. gamma-Aminobutyric acid concentration in cerebrospinal fluid in schizophrenia.
    McCarthy BW; Gomes UR; Neethling AC; Shanley BC; Taljaard JJ; Potgieter L; Roux JT
    J Neurochem; 1981 Apr; 36(4):1406-8. PubMed ID: 7264636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients.
    Hashimoto K; Engberg G; Shimizu E; Nordin C; Lindström LH; Iyo M
    BMC Psychiatry; 2005 Jan; 5():6. PubMed ID: 15683541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.